Concepedia

Lok Ka Lam

LK

Statistics

Publications

3

Citations

125

H-Index

3

Active since

2021

Affiliations

Queen Mary Hospital(Current)

University of Hong Kong

University of Hong Kong - Shenzhen Hospital

Lok Ka Lam is an author at Queen Mary Hospital specializing in steatosis quantification, pharmacotherapy, and hepatic steatosis assessment.

ORCID

Publications per year

2021–2024

3

Publications

3

Use of Antibiotics during Immune Checkpoint Inhibitor Treatment Is Associated with Lower Survival in Hepatocellular Carcinoma

Ka Shing Cheung, Lok Ka Lam, Wai Kay Seto et al. · Liver Cancer · 2021 · 65 citations · Full text

, , +15

Effects of empagliflozin on liver fat in patients with metabolic dysfunction–associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial

Ka Shing Cheung, Ho Yu Ng, Rex Wan Hin Hui et al. · Hepatology · 2024 · 41 citations

, , +17

Effect of moderate-to-severe hepatic steatosis on neutralising antibody response among BNT162b2 and CoronaVac recipients

Ka Shing Cheung, Lok Ka Lam, Rex Wan Hin Hui et al. · Clinical and Molecular Hepatology · 2022 · 19 citations · Full text

, , +17

1–3 of 3